2,3-dinor-thromboxane b2 has been researched along with Pulmonary Hypertension in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adatia, I; Barrow, SE; Haworth, SG; Miall-Allen, VM; Ritter, JM; Stratton, PD | 1 |
Bernard, GR; Christman, BW; Groves, BM; King, GA; Loyd, JE; McPherson, CD; Newman, JH | 1 |
Cotton, RB; Kühl, PG; Schweer, H; Seyberth, HW | 1 |
3 other study(ies) available for 2,3-dinor-thromboxane b2 and Pulmonary Hypertension
Article | Year |
---|---|
Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aging; Cardiac Surgical Procedures; Child; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Male; Postoperative Period; Pulmonary Heart Disease; Reference Values; Thromboxane A2; Thromboxane B2 | 1993 |
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Radioimmunoassay; Thromboxane A2; Thromboxane B2 | 1992 |
Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Bacterial Infections; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Thromboxane A2; Thromboxane B2 | 1989 |